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SUMMARY 
The genome of the autonomous parvovirus minute virus of mice (MVM) is organized 
in two overlapping transcription units: the genes coding for the two non-structural 
proteins (NS-1 and NS-2) are transcribed from a promoter (P04) located at map unit 4, 
whereas the promoter controlling the capsid protein genes (P39) lies at map unit 39. We 
studied the effect of viral proteins on the activity of the P39 promoter in vivo. By site- 
directed mutagenesis we constructed clones encoding only one of the two NS proteins. 
The activity of the P39 promoter was measured in HeLa or EL-4 cells transfected with 
these clones, either by an RNase protection assay or by following the expression of a 
reporter gene, CAT (which codes for chloramphenicol acetyltransferase), placed under 
the control of this promoter. We found that the P39 promoter of strain MVMi is 
activated in trans by a viral gene product, and evidence to suggest that NS-1 is the only 
viral gene product responsible for this trans-activation. We also determined that the 
mechanism of trans-activation is very rapid, since all species of viral mRNAs appear 
together in non-synchronized infected EL-4 cells within a 2 h interval. 
INTRODUCTION 
The parvoviruses are small, non-enveloped icosahedral viruses with a genome consisting of a 
single-stranded DNA molecule 5kilobases long with hairpin structures at both extremities. The 
autonomous parvoviruses are able to grow only in actively dividing cells, presumably because 
they are dependent on a factor specific to the S-phase of the cell cycle (reviewed in Berns, 1984; 
Ward & Tattersall, 1978). 
Two strains of the autonomous parvovirus minute virus of mice (MVM) have been isolated, 
one of them, MVMp, infecting fibroblasts and the other, MVMi, infecting lymphocytes 
(Crawford, 1966; Bonnard et al., 1976; Engers et al., 1981 ; McMaster et al., 1981 ; Tattersall & 
Bratton, 1983). The DNA sequences of both strains have been determined (Astell et al., 1983, 
1986, Sahli et al., 1985). 
It has been shown that the genomic organization of MVM consists of two overlapping 
transcription units, with promoters at map units 4 and 39 (these promoters will be referred to as 
P04 and P39 respectively). The leftward part of the genome contains the genes for two non- 
structural proteins (NS-1 and NS-2) placed under the control f the P04 promoter, whereas the 
P39 promoter controls the transcription of the capsid genes located in the rightward part of the 
genome (Pintel et al., 1983; Cotmore & Tattersall, 1986; Jongeneel et al., 1986). The capsid 
messenger RNAs (two species) all share the same 5' end, and the polyadenylation signal used by 
all the viral transcripts i located very near the right-hand end of the genome (Clemens & Pintel, 
1987). 
The trans-activation ofviral promoters by viral gene products has been known for a long time 
in many different systems, e.g. adenoviruses (Nevins, 1981), papovaviruses (Brady et al., 1984; 
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Keller & Alwine, 1984) and herpesviruses (Post et al., 1981). That this phenomenon also occurs 
in parvoviruses became evident only in 1985. Rhode (1985) showed that the P38 promoter of the 
autonomous parvovirus H-1 was activated in trans by a viral gene product encoded on the left 
part of the genome, and that this activation was lost if the NS-1 protein-coding sequence was 
altered by a frameshift mutation situated roughly in the middle of the gene. These data povided 
evidence that in H-I NS-1 plays a role in the trans-activation of the capsid genes' promoter. 
However, it was not possible to exclude the possibility that NS-2 might be the trans-activator, 
and that its expression or function may be altered if NS-1 is non-functional. Cotmore & 
Tattersall (1988) have shown that NS-1 of MVMi binds to the 5' end of the viral DNA which 
suggests that this protein has at least two functions. In this paper, we show that during infection 
by the autonomous parvovirus MVMi a trans-activation of the P39 promoter also occurs, and 
furthermore we present strong evidence that NS-1 is the only viral gene product required for this 
phenomenon. 
METHODS 
Molecular cloning. We followed the protocols given by Maniatis et al. (1982). Restriction endonucleases, T4
DNA ligase and T4 DNA polymerase were purchased from Boehringer Mannheim. The plasmids were amplified 
in the HB101 strain of Escherichia coli. 
Plasmid construction. For a representation f the plasmids used see Fig. 1. 
pMP39-CAT. To obtain this plasmid, we isolated the BstNI restriction fragment containing nucleotides (nO 
1820 to 2080 from MVMi DNA, rendered it blunt-ended using T4 DNA polymerase and ligated it to HindlII 
linkers. We then inserted it into the Hind1II cloning site of pSV0-CAT (Gorman et al., 1982 a). This vector did not 
contain any element from the regulatory region of simian virus 40 (SV40). Restriction analysis of the 
transformants with AvaI allowed determination f the orientation f the insert relative to the chloramphenicol 
acetyltransferase (CAT) gene. pMP39-CAT refers to the plasmid containing the fragment in the orientation 
needed for transcription of the CAT gene from the P39 promoter. 
pEMBL/iO099. The construction of this plasmid has already been described (Antonietti et al., 1987); it is an 
almost full-length genomic lone of MVMi, lacking only some base pairs of the terminal hairpins, inserted through 
SalI linkers into the pEMBL9 vector (Dente et al., 1983). 
pEMBL/iO052. This plasmid was made by deleting the HindlII fragment (nt 2651 to 5104) from 
pEMBL/i0099. Thus it contained the two promoters and entire genes for the NS proteins, but lacked the major 
part of the capsid genes as well as the polyadenylation signals used by all viral mRNAs. 
pMNS-1 '~. This plasmid was unable to express NS-1. We obtained it by cutting pEMBL/i0099 with BstEII, 
filling the 5' overhangs using T4 DNA polymerase and religating the plasmid. Since the only BstEII site on 
pEMBL/i0099 was located within the large intron of the NS-2 gene at position 1885 (Jongeneel et al., 1986), we 
thus created a frameshift mutation affecting only the sequence of NS-1 gene. 
pMNS-2 m. This plasmid was unable to express NS-2, but still expressed NS-1. We produced it by 
oligonucleotide-directed site-specific mutagenesis. Site-specific mutation was carried out by standard techniques 
of oligonucleotide-directed mutagenesis using a single-stranded bacteriophage WB239 DNA template (Barnes & 
Bevan, 1983; Sahli et al., 1985) and a partially mismatched oligonucleotide asa mutagenic primer (Zoller & Smith, 
1983). The EcoRI-EcoRI fragment (positions 1085 to 3523) isolated from pEMBL/i0099 was inserted into the 
EcoRI site of bacteriophage WB239. This clone was used for isolation of single-stranded template DNA, to which 
the 21-mer mutagenic oligonucleotide (DNA Synthesizer model 380 B, Applied Biosystems) was hybridized. 
The primer-extended products were used to transform E. coli WB373 cells. Since the mutation generated by 
the oligonucleotide r sults in the loss of the Xhol site at position 2071 (the recognition sequence of XhoI is 
5'-CTCGAG-3'), we screened the transformants for the lack of this XhoI site (Fig. 5a). The mutants were then 
plaque-purified and sequenced according to Sanger et al. (1977). To reconstitute a clone containing the whole 
length of MVMi and carrying this mutation, we substituted the mutated EcoRI-EcoRI fragment o the 
corresponding EcoRI-EcoRI (nt 1085 to 3523) fragment of pEMBL/i0099. 
pMNS-2~cal~. The only viral protein this clone could express was NS-1. We obtained it by linearizing 
pMNS-2 m with SpeI (position 3001), rendering the extremities blunt-ended using T4 DNA polymerase and 
inserting into this phosphorylated site anon-phosphorylated decamer HindIII linker. This resulted in a frameshift 
in the 5' part of the capsid genes. We checked for the presence of a single decamer linker by comparing on a 
sequencing gel the sizes of the BglI-DraI fragments (nt 2877 to 3012) obtained by restriction of either pMNS-2 mor 
pMNS-2mcap r~, using dideoxy sequencing reaction products as size markers (data not shown). 
Cell culture. HeLa and EL-4 cells were grown in Dulbecco's modified Eagle's medium supplemented with 5% 
foetal bovine serum. EL-4 is a murine lymphoma-derived cell line and is the usual host for lytic infection with 
MVMi (Bonnard et al., 1976). 
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Fig. 1. Clones used during this study. The top bar represents he viral genome. The main open reading 
frames are drawn beneath. For each clone a representation is given of its coding capacity. (a) 
pEMBL/i0099; (b) pEMBL/i0052; (c) pNS-lm; (d) pNS-2m; (e) pNS-2mcapm; (f) pMP39-CAT. 
Frameshift mutations are represented bya vertical bar with an asterisk above. El, pEMBL; [], pSV0- 
CAT; I-q, functional ORF; [], shifted frame. 
TransJections. The transfections into HeLa cells were performed by using the calcium phosphate procedure 
described by Graham & van der Eb (1973). We transfected DNA into EL-4 cells following the DEAE~lextran 
method escribed previously (Sompayrac & Danna, 1981 ; Banerji et al., 1983). The DNA to be transfected was 
quantified with a DNA minifluorimeter (Hoefer Instruments). 
CATassays. The preparation of extracts from transfected cells and the measurement of heir CAT activity were 
done according to a modification of the procedure described by Gorman et al. (1982a). The cells were harvested 
45 h after transfection and resuspended in 100/al of 250 mr, l-Tris-HCl pH 7.5; the extracts were obtained by three 
consecutive cycles of freeze-thaw lysis followed by centrifugation at 4 °C to remove cell debris. The assay mixture 
(45 I11) contained 20 Ill of cell extract, 1 lal of [~ ~C]chloroamphenicol (0.2mCi/ml, 54 mCi/mmol), 5p,I 4.4 (or up to 
44) mM-acetyl-coenzyme A and 19 ~tl 250 mM-Tris HCI pH 7.5. The reaction was carried out at 37 °C for 14 h and 
stopped with 0.5 ml of ethyl acetate, which was also used to extract he chloramphenicol and its acetylated 
derivatives. The organic layer was lyophilized, and the chloramphenicol taken up in 30 ~tl of ethyl acetate, spotted 
on silica gel thin-layer plates and run with chloroform-methanol (95 : 5). The plate was then dried and exposed to 
film for autoradiography. 
Extraction of cytoplasmic RNA and RNaseprotection assays. Infected EL-4 cells were lysed with Nonidet P40, the 
nuclei were removed, and the cytoplasmic RNA was isolated as described by Maniatis et al. (1982). 
The RNase protection assays were performed as described previously (Melton et al., 1984; Zinn et al., 1983). 
The RNA probe (Fig. 2b) was synthesized with SP6 RNA polymerase (Green et al., 1983) from the plasmid 
pSP64-iHX which was constructed by insertion of the HaelI I -Xhol fragment (nt 1854 to 207l) isolated from 
MVMi double-stranded replicative form into pSP64 between the Sail and Sinai sites (Antonietti et af., 1987). 
RESULTS 
T ime course o f  r iral transcription in M VMi- in. /ected EL -4  cells 
We infected non-synchronized EL-4 cells with MVMi  and extracted the cytoplasmic RNA 6, 
8, 10, 12 and 24 h after infection. The viral mRNAs  were detected by hybr id izat ion of  5 lag of 
cytoplasmic RNA with the SP6 RN A probe descr ibed in Methods,  followed by digestion of the 
s ingle-stranded RNA with RNase  A and RNase  TI .  We denatured the protected f ragments at 
100 °C for 5 min  in formamide,  and analysed their  lengths by electrophoresis in polyacry lamide-  
urea sequencing els. A f ragment  of 217 nt should be protected by the NSI mRNA (RI) ,  the 
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Fig. 2. (a) Map of MVMi showing the three major transcripts. (b) An enlargement of the region in 
which the HaelII (1854)--Xhoi (2071) RNA probe hybridizes with the mRNAs. Bold lines indicate the 
regions protected against RNase by hybridization to the SP6-generated MVMi-derived RNA probe. 
The R3 cap site lies approximately at nt 2005 and the acceptor site of the large splice within R2 at nt 
1990. The numbers to the right indicate the expected size (in nO of the hybridized region. (c) Time 
course of viral transcription i  MVMi-infected EL-4 cells. We infected lymphocytes with MVMi and 
extracted the cytoplasmic RNA after 6 (lane 1), 8 (lane 2), 10 (lane 3), 12 (lane 4) and 24 (lane 5) h. We 
detected the viral mRNAs by RNase protection using the probe described in Methods. The single- 
stranded Mr markers (lane 6) were fragments of pBRSV40 digested with HinfI. Their lengths (in nO are 
indicated to the right of the gel. 
NS2 mRNA (R2) should protect a fragment of 81 nt, and the capsid (VP1 and VP2) mRNAs  
(R3) should protect a fragment of about 60 nt (Fig. 2). The results are shown in Fig. 2. We did not 
detect any viral mRNA 6 and 8 h after infection, but after 10 h the three types of viral mRNAs  
were visible; the amount of viral transcripts increased betweeen 10 and 24 h. The VP 1 and VP2 
mRNAs seem to have appeared at the same time as the NS1 and NS2 mRNAs;  thus we did not 
observe an early phase during which only the genes for non-structural proteins were transcribed, 
followed by a late phase in which most of  the mRNA was specific for capsid genes. Instead we 
observed a burst of all the viral mRNAs  between 10 and 12 h after infection. By performing the 
same kind of experiments using synchronized cells, Clemens & Pintel (1988) did detect such 
early and late phases. 
C- 
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Fig. 3. Trans-activation f P39 promoter in HeLa cells, pMP39-CAT (2 ~zg) was transfected into HeLa 
cells following the calcium phosphate procedure. Various amounts of pEMBL/i0099 were added to the 
transfection mixture (lane 1, no addition; lane 2, 0.04 ~tg; lane 3, 0.2 Isg; lane 4, 1 Isg; lane 5, 5 p.g). A 
indicates chloramphenicol, and B and C indicate two forms of acetylated chloramphenicol. 
The P39 promoter of  MVMi  is activated in trans by a viral gene product 
In order to test the possibility of trans-activation of the P39 promoter by a viral gene product, 
we used the bacterial CAT gene as a marker gene to monitor the transcriptional ctivity of 
MVMi P39 promoter (Gorman et al., 1982). For this purpose we constructed the plasmid 
pMP39-CAT, which contained a 260 bp fragment carrying the P39 promoter TATA box (with 
about 160 bp of the upstream region and 100 bp of the downstream region) in front of the CAT 
gene, in the orientation allowing transcription of this gene from the viral promoter. We first 
chose to test the activity of P39 in HeLa cells, since we had already shown that this promoter 
yields run-off transcripts in HeLa cell extracts (unpublished observations). Upon transfection of
pM39-CAT into HeLa cells, the amount of CAT activity in the cells was very low (Fig. 3, lane 1). 
However, when different amounts of pEMBL/i0099 (a plasmid containing both complete 
transcription units of MVMi) were included in the transfeeted DNA, a dramatic increase in the 
expression of CAT was observed; the extent of this increase depended on the amount of 
pEMBL/i0099 added in the transfection. This effect was not seen when the 260 bp fragment was 
inserted in the other orientation relative to the CAT gene (data not shown). From these 
observations we conclude that a viral gene product was able to activate the P39 promoter in 
trans. We repeated this experiment using the MVMi host cell line EL-4 (Fig. 4, lanes 3 and 4). By 
counting the radioactivity in the fastest migrating spots, we determined that the activity of the 
P39 promoter was enhanced about 60-fold in the presence of viral gene products. 
One or both NS proteins play a role in the trans-activation of the P39 promoter 
From the experiment described above it was not possible to deduce which of the viral proteins 
was responsible for the trans-activation. One could imagine that it was due to one of the non- 
structural proteins controlled by the P04 promoter, or to a positive feedback regulation by the 
capsid proteins. To discriminate between these possibilities, we transfected EL-4 cells with a 
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Fig. 4. Determination fthe viral protein responsible for the activation of the P39 promoter in EL-4 
cells. EL-4 cells were transfected with 5 ~ g of pMP39-CAT and 0.5 ~tg of various clones (lane 3, no 
plasmid; lane 4, pEMBL/i0099; lane 5,pEMBL/i0052; lane 6,pMNS-2m; lane 7,pMNS-lm; lane 8, 
pMNS-2mcapm). The controls were: lane 1, cells transfected with 5 vtgof pRSV-CAT (in which the CAT 
gene is under the control of the strong promoter of Rous sarcoma viru s) (Gorman et al., 1982 b), and lane 
2, cells transfected with 5 Ixg ofpSV0-CAT without a promoter. A indicates chloramphenicol, and B 
and C indicate two forms of acetylated chloramphenicol. 
mixture of pMP39-CAT and pEMBL/i0052, a clone containing only the left part of MVMi 
genome, from nt 0 to the HindIII site at nt 2651. The coding capacity of this clone was restricted 
to the non-structural proteins, since it contained only about 300 nucleotides of capsid 5' coding 
sequence. The level of CAT activity in such transfected EL-4 cells is shown in Fig. 4, lane 5. This 
clearly demonstrates that the viral genes located in the left part of the genome played a role in the 
trans-activation of the P39 promoter. The trans-activation observed in cells cotransfected with 
pEMBL/i0052 and pMP39-CAT (lane 5) was somewhat less efficient han that observed when 
the added DNA was pEMBL/i0099 (lane 4). This is presumably because the polyadenylation 
signals used for all the viral transcripts (including those coding for NS-1 and NS-2) were located 
very near the right end of the genome and thus absent from pEMBL/i0052. However, we cannot 
exclude that the capsid proteins are needed in conjunction with one or both NS proteins to 
restore a full level of trans-activation. 
At this point there remained four possibilities: the viral protein(s) functioning as a trans- 
activator could be (i) NS-1, (ii) NS-2 or (iii) both of them in conjunction, or (iv) the capsid 
proteins are needed in addition to one or both NS proteins to generate maximal trans-activation. 
To determine which was in fact involved, we had to construct plasmids expressing only one of 
the two non-structural proteins and test their capacity to activate the P39 promoter in 
transfected cells. 
Construction of  defective mutants 
To construct a clone of MVMi unable to express NS-2 but still expressing NS-1, we introduced 
a mutation in a region where NS-1 and NS-2 used different reading frames. We substituted a 
thymidine for a cytosine at position 2073, so that the amino acid sequence of NS-1 was not 
altered (because both CTC and CTT code for a leucine residue), but the codon CGA coding for 
an arginine in NS-2 was changed into a TGA stop codon (see Fig. 5a). The mutant and the wild- 
type DNA were compared by dideoxy sequencing, and the results are shown in Fig. 5 (b). They 
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clearly show that the mutant had the expected DNA sequence. In this figure the synthesized 
strands have a polarity opposite to that of the viral mRNA, so we read Y-TCCTCGAGATC-Y 
for the wild-type and 5'-TCCTCAAGATC-Y for the mutant. This mutant will be referred to as 
pMNS-2 m. We also constructed a mutant (pMNS-1 m) which was able to express NS-2 and 
capsid proteins, but not NS-1 (see Methods). pMNS-I m no longer contained the BstEII site, and 
clearly had a mutant phenotype (see below). 
NS-I is the only NS protein needed for the trans-activation f the P39 promoter 
When we tested the ability of pMNS-1TM (which was able to express NS-2 but not NS-1) to 
trans-activate he P39 promoter, by cotransfecting it into EL-4 ceils with pMP39-CAT and 
subsequently assaying CAT activity in cell extracts (Fig. 4, lane 7), we observed a signal similar 
in strength to that provided by extracts ofcells transfected by pMP39 alone (lane 3). In a similar 
experiment we replaced pMNS-I m by pMNS-2 m (which was able to express NS-1but not NS-2); 
this restored the trans-activation f the P39 promoter, and caused asignal (lane 6) similar to that 
observed when the DNA cotransfected with pMP39-CAT was the whole length clone 
pEMBL/i0099 (lane 4). Thus we conclude that NS-I is implicated in the trans-activation, and 
that NS-2 plays no role in this phenomenon. 
There is no positive feedback regulation of the P39 promoter by capsid proteins 
The last point to clarify was that the CAT activity was lower in cells transfected with a 'tram- 
activator' clone lacking the right-hand part of the genome (pEMBL/i0052; Fig. 4, lane 5) than in 
cells transfected with a clone containing the whole length of the viral genome (pEMBL/i0099 or 
pMNS-2 ~; Fig. 4, lanes 4 and 6). To determine whether or not this was due to a role of the capsid 
proteins in the trans-activation, we modified the plasmid pMNS-2 m in such a way that the 
altered clone (pMNS-2mcap TM) could no longer express capsid proteins. This was done by 
insertion of a linker in the 5' region of the capsid protein-coding sequence (position 3001), which 
resulted in a frameshift in this gene (see Methods). Upon cotransfection f pMP39-CAT and 
pMNS-2mcap minto EL-4 cells, we observed a trans-activation of the P39 promoter that was 
equivalent to that generated by pEMBL/i0099 or pMNS-2 m (Fig. 4, lane 7). We obtained this 
result with two independent pMNS-2mcap mclones. The experiments presented in Fig. 4 were 
repeated several times and the results were highly reproducible. From these data we conclude 
that NS-I is the only viral protein required for the trans-activation of the P39 promoter. 
Evidence that the activation by NS-1 increases mRNA concentration 
It could be imagined that the increase in the CAT signal in the presence of NS-1 in transfected 
cells resulted from some mechanism other than enhancement of transcription, e.g. increased 
efficiency of translation of the RNA. To test this possibility, we transfected EL-4 cells with 
pEMBL/i0099, pMNS-1 m or pMNS-2m; after 24 h we extracted the cytoplasmic RNA and 
analysed viral mRNAs by the RNase protection method escribed above. The results are shown 
in Fig. 6. By comparing the abundance of the capsid mRNA in the presence or absence of 
functional NS-2 (Fig. 6, lanes 1 and 3) we observed that the P39 promoter had the same activity 
in both cases. On the other hand, the transcription pattern of the transfected clone coding for an 
abortive NS-1 (pMNS-1 m) was drastically modified: in this case we observed neither NS-2 
mRNA nor capsid mRNA (lane 2). Thus this kind of approach confirms the data obtained with 
the CAT assays, and gives evidence that the activator effect of NS-I on the products controlled 
by the P39 promoter was at the level of mRNA concentration. 
DISCUSSION 
We have studied the regulation of transcription i  the autonomous parvovirus MVMi. In 
particular we have shown that the non-structural protein NS-1 is necessary and sufficient for the 
trans-activation f the P39 promoter. This was shown by using a plasmid that coded for NS-1, 
but not for NS-2 or the capsid proteins. Cotransfection with a plasmid that contains the CAT 
gene under the control of the P39 promoter led to a strong increase in the production of CAT. 
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Fig. 6. Transcription pattern of different clones 
transfected into EL-4 cells. We transfected EL-4 
with 2 ~tg of linearized pEMBL/i0099, pMNS-1 m 
or pMNS-2 m following the DEAE~iextran 
method. After 24 h we xtracted the cytoplasmic 
RNA and analysed 5 ~g of each RNA using the 
RNase protection assay. Cells were transfected 
with (lane 1) pEMBL/i0099, (lane 2) pMNS-1 m or 
(lane 3) pMNS-2 m. The fragment protected by the 
NS-1 mRNA transcribed from pMNS-1 m was 
truncated because the mutation a  the BstEII site 
introduced a mismatch between the probe and the 
NS-I mRNA, so that the probe was cleaved by 
the RNase at this position, and a new protected 
fragment of about 190 nt appeared (lane 2). In a 
similar way, the difference between the VP 
mRNA-protected fragments (a double band in 
lane 1 and a single band in lane 3) reflects the fact 
that the mRNA sequences are different at 
position 2073:pMNS-2 is mutated at this 
position. The single-stranded Mr markers are 
fragments of SV40 DNA digested with HinfI. 
The lengths (in nt) are indicated to the right of t e
gel. 
Analysis by RNase protection assays of viral transcripts expressed in transfected cells leads to 
the same conclusion. Rhode (1985) has shown that the P38 of parvovirus H-1 is trans-activated 
by a non-structural gene product, and that this trans-activation disappears if the NS-1 gene is 
specifically altered. Our study with MVMi confirms these data and goes further by providing 
evidence that NS-1 is directly responsible for the trans-activation, and that neither NS-2 nor 
capsid proteins play any role in this process. Moreover we have checked (by RNase protection 
analysis) that the effect of NS-1 on expression of the CAT gene placed under the control f the 
P39 promoter really does reflect an increase in the concentration f the RNA transcribed from 
this promoter. This increase in the capsid mRNA level in the presence of NS-1 could have been 
due either to a faster transcription rate, or to increased stability of the mRNA. Since the stability 
of mRNA is in general modulated by the 3' end of the molecule (Owen & Kfihn, 1987), and since 
in our CAT experiments he only viral sequence present in the mRNA is a short part of the 5' 
end, we suppose that the presence of NS-1 results in an increased transcription rate from the P39 
promoter. Providing evidence for this will require run-on transcript analysis. 
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Rhode has defined a short sequence placed upstream of the H-1 P38 promoter which is 
necessary for the trans-activation and which he named the TAR element (for trans-activation 
responsive) (Rhode & Richard, 1987). A closely related sequence is present upstream of the P39 
promoter on the MVMi 260 bp fragment that we inserted into pSV0-CAT (around nt 1870). 
The transcription pattern of pMNS- I  m is such that the NS-1 and NS-2 mRNAs  are present in 
lesser amounts than in the case of clones which are able to express NS-1 (Fig. 6). This indicates 
that NS-1 may play a role in the regulation of the P04 promoter. We are currently testing this 
hypothesis. It is also noticeable that in the transcription pattern of pMNS-2 m the relative 
amount of NS-2 mRNA is lower than in the transcription pattern of pEMBL/i0099 (Fig. 6). This 
could mean that NS-2 has a positive feedback action on the production of its own mRNA.  More 
work is needed to clarify this point. 
When we analysed the time of appearance of specific viral mRNAs  during an infection of EL- 
4 cells by MVMi, we did not detect wo phases of viral transcription, with the non-structural 
genes being expressed first and the capsid genes being activated later on, as can be observed in 
other viral systems. Instead, we observed that all species of viral transcripts eem to appear 
simultaneously. This indicates that under our experimental conditions the time needed for the 
activation of the P39 promoter by NS-1 was too short to be noticed. By analysing the appearance 
of viral mRNA in synchronized infected cells, Clemens & Pintel (1988) have recently 
demonstrated that early and late phases do exist. 
Cotmore & Tattersall (1988) have recently shown that NS-1 is bound covalently to the 5' end 
of the viral genome; the functional aspect of this interaction is not yet understood. Our data 
show that this association is not required for the trans-activation, since this phenomenon occurs 
when only a small fragment of viral DNA carrying the promoter is inserted into a plasmid. This 
suggests that this protein plays at least two r les during the infection. We are currently studying 
the interaction between NS-1 and the P39 promoter. 
We thank B. Bentele for efficient help with tissue culture, and V. Jongeneel for valuable discussions. This work 
was supported by the Fonds National de la Recherche Scientifique and the University of Lausanne. 
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